Documenting symptom and context changes in individual case safety reports: a methodological perspective

Individual case safety report narratives support pharmacovigilance by preserving clinical chronology and contextual information. A possible information gap concerns how documented symptom changes, surrounding circumstances, and actions already taken are linked and attributed to their sources. Its frequency and consequences have not been established. This Perspective proposes a minimal representation of symptom trajectories, context, actions, subsequent responses, concurrent changes, and remaining uncertainty. A limited procedural inspiration is the repeated observation and revision of working hypotheses used in dynamic psychotherapy; this does not establish a new pharmacovigilance diagnostic method. The proposal builds on existing case processing, causality frameworks, quality assessment, and follow-up practice. Evaluation would first audit source records and processing histories, then compare the proposed representation with optimized routine narratives containing the same facts. An independently adjudicated reference would specify what the records support, without claiming to establish biological causality. The primary endpoint would be correct reconstruction of prespecified case information; unsupported conclusions, completion, and workload would be assessed separately. Additional questioning would require a later, distinct evaluation of information yield, nonresponse, recall, and questioning effects. Contextual information must not delay reporting or justify unsupported dismissal of a medicinal-product contribution. The representation warrants testing, including the possibility that good routine processing already provides equivalent practical information.

Authors

Publication Details

Journal
Frontiers in Drug Safety and Regulation
Published
2026-10-28
DOI
https://doi.org/10.3389/fdsfr.2026.1885733
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Documenting symptom and context changes in individual case safety reports: a methodological perspective

Eik Niederlohmann
1 links
Frontiers in Drug Safety and Regulation
Pharmacovigilance and Adverse Drug Reactions
article

Documenting symptom and context changes in individual case safety reports: a methodological perspective

Eik Niederlohmann
article en

Abstract

Individual case safety report narratives support pharmacovigilance by preserving clinical chronology and contextual information. A possible information gap concerns how documented symptom changes, surrounding circumstances, and actions already taken are linked and attributed to their sources. Its frequency and consequences have not been established. This Perspective proposes a minimal representation of symptom trajectories, context, actions, subsequent responses, concurrent changes, and remaining uncertainty. A limited procedural inspiration is the repeated observation and revision of working hypotheses used in dynamic psychotherapy; this does not establish a new pharmacovigilance diagnostic method. The proposal builds on existing case processing, causality frameworks, quality assessment, and follow-up practice. Evaluation would first audit source records and processing histories, then compare the proposed representation with optimized routine narratives containing the same facts. An independently adjudicated reference would specify what the records support, without claiming to establish biological causality. The primary endpoint would be correct reconstruction of prespecified case information; unsupported conclusions, completion, and workload would be assessed separately. Additional questioning would require a later, distinct evaluation of information yield, nonresponse, recall, and questioning effects. Contextual information must not delay reporting or justify unsupported dismissal of a medicinal-product contribution. The representation warrants testing, including the possibility that good routine processing already provides equivalent practical information.

Frontiers in Drug Safety and RegulationVol. 6
Good health and well-being
Openalex Percentile: Top 15%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Documenting symptom and context changes in individual case safety reports: a methodological perspective — Eik Niederlohmann · Frontiers in Drug Safety and Regulation (2026) | TGRS Research Map | TGRS